Not Yet Recruiting Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children NCT06763315 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more Locations West China Hospital of Sichuan University — Chengdu, Sichuan, China View Trial Details
Active, Not Recruiting MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas NCT02407405 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
